Aeglea Bio Therapeutics Inc
Biotechnology
Healthcare
AGLE
95.57 B shares
NASDAQ US
traded
27 Nov 2023
listed
no
open
10.87
52 week high
14.94
high
12.34
52 week low
1.35
low
10.69
growth
-14.21 %
previous Close
11.04
P/E ratio
-7
market cap
35.79 M
div yield
0
usd
Jun 2023
qoq
revenue
688 K
0.00 %
net incoming
-217.08 M
0.00 %
eps
-1.66 %
-730.00 %
eps surprise
-822.22 %
net profit margin
-31552.47 %
-31552.00 %
operating incoming
-159.25 M
0.00 %
net change in cash
0.00 %
cash on hand
235 M
0.00 %
cost of revenue
0.00 %
top top